ARCHIVES

The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year

This article is from The Cancer Letter archive.

Vol. 38 No. 16 | April 20, 2012

Download PDF Visit The Full Archive

Related Articles

RFA On Promoters, Hormones, Other Cofactors Available

July 17, 1981

Cancer Leadership Council Letter Calls For Permanent Leadership of NCI and FDA.

November 22, 2006

DCPC Board Finally Approves Prescribe for Health Concept on 7-4 Vote, Okays RFA On Micronutrients

October 21, 1988

Obama Plan Would Double Cancer Funding, Increase Clinical Trial Enrollment To 10%.

November 7, 2008

FDA approves Irinotecan, Days After ODAC Meeting

June 21, 1996

NCI Planning Phase III Study Of Avastin For Metastatic Colorectal Cancer

June 27, 2003